New pill aims to put the brakes on fatal lung scarring
Disease control
Recruiting now
This study is testing whether a daily oral medication called ifetroban can slow the progression of idiopathic pulmonary fibrosis (IPF), a serious disease that causes permanent lung scarring. About 128 patients will take either the drug or a placebo pill for one year to see if it …
Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC